Jonathan Hill, James Spratt, Charalambos Antoniades, et al

Watch time: 11h 6m 44s (20 videos)

About

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Articles

A17 - Vascular Complications in Patients with STEMI and Cardiogenic Shock with Percutaneous Mechanical Circulatory Support Devices: Prevalence and Clinical Outcomes from a Large Nationwide Database

Published:

11 November 2019

Citation:

Interventional Cardiology Review 2019;14(3 Suppl 1):A17.

A15 - Impella Mechanical Circulatory Support for Takotsubo Syndrome with Shock

Published:

11 November 2019

Citation:

Interventional Cardiology Review 2019;14(3 Suppl 1):A15.

A14 - Haemodynamic and Metabolic Changes Due to Left Ventricular Unloading by Impella Heart Pump in Patients Suffering from Cardiogenic Shock Within 24 Hours: Results from the Jenamacs Impella Registry

Published:

11 November 2019

Citation:

Interventional Cardiology Review 2019;14(3 Suppl 1):A14.

A13 - A Matched-pair Analysis of the Association Between Early Use of Impella CP or IABP and 30-day Mortality in Patients with Acute MI and Cardiogenic Shock

Published:

11 November 2019

Citation:

Interventional Cardiology Review 2019;14(3 Suppl 1):A13.